Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 27INDUSTRY 3FED 1

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 2870Carcinoma, Non-Small-Cell Lung 2420Breast Neoplasms 2065Colorectal Neoplasms 1239Neoplasm Metastasis 1223Prostatic Neoplasms 1076Melanoma 972Multiple Myeloma 960Ovarian Neoplasms 899Recurrence 849Leukemia, Myeloid, Acute 807Lung Neoplasms 756Pancreatic Neoplasms 750Lymphoma, Non-Hodgkin 726Lymphoma 660Stomach Neoplasms 622Carcinoma, Hepatocellular 564Carcinoma, Renal Cell 544Squamous Cell Carcinoma of Head and Neck 525Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 449Glioblastoma 435Advanced Solid Tumors 430Small Cell Lung Carcinoma 408Triple Negative Breast Neoplasms 407Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 367Advanced Solid Tumor 349

Interventions

Inositol 2Lactalbumin 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Chorionic Gonadotropin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Anovulation × Clear all
NCT03667443 2025-07-11

Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

Lo.Li.Pharma s.r.l

Phase NA Completed
50 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT03422289 2018-02-06

Improved Effects of MI Plus Alpha-LA in PCOS

Lo.Li.Pharma s.r.l

Phase NA Completed
37 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT01653743 2016-01-07

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
81 enrolled 11 charts

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡